After receiving adverse reports involving five animals, Australia-based Jurox Animal Health voluntarily recalled two lots of the widely used intravenous injectable anesthetic Alfaxan unpreserved last week, according to the US Food and Drug Administration (FDA). The reason for the recall: The presence of aluminum phosphate precipitate, which, when injected, presents a possible risk of blood vessel inflammation and formation of potentially life-threatening blood clots.
You could have a say on the future of veterinary education. The American Veterinary Medical Association (AVMA) Council on Education (COE) Selection Committee is seeking interested and qualified veterinarians to serve on the council. Per the AVMA, “This is one of the most important volunteer roles that AVMA members can fill.”
When it’s all about quality of care, everyone’s on board. The American Veterinary Medical Association (AVMA), American Association of Veterinary State Boards (AAVSB), Association of American Veterinary Medical Colleges (AAVMC) and National Association of Veterinary Technicians in America (NAVTA) on Thursday released a joint statement of support for
The U.S. Food and Drug Administration (FDA) is reporting a shortage of three pain relief drugs: fentanyl, morphine and hydromorphone. The shortage is due to upgrades being made at a pharmaceutical manufacturing plant in Kansas, and is unrelated to any federal policies on opioids or manufacturing quotas, according to FDA officials.
In the wake of the Tropical Depression Harvey disaster, Texas Gov. Greg Abbott has made it easier for Texas veterinarians to treat animals affected by the storm.
The World Health Organization (WHO) may be considering another proposed change to the international scheduling of ketamine, and the AVMA is seeking the profession’s help in asking the US Food and Drug Administration (FDA) to protect veterinarians’ access to this critical drug. The AVMA is drafting a letter to the FDA that will outline how critical ketamine use is in veterinary medicine and how important it is that it remain available to U.S. veterinarians, and is requesting your help during this urgent time to reinforce the message.
It appears that Congress will pass an eleventh-hour Tax Extenders Bill, a package of 55 tax breaks for businesses and individuals that will cost approximately $45 billion.
The US Food and Drug Administration (FDA) gave veterinarians the green light to use cannabis in the treatment of pets—in a manner of speaking. Put it this way: It didn’t say they couldn’t. Here’s what happened.
Catch up on the latest pet and veterinary news from the last week. In this update: a New York bill proposes banning declawing, the FDA sends warning letters about unproven cancer treatment claims, the University of Arizona faces new hurdle in creating veterinary school, and the world welcomes a litter of endangered red wolf pups.
The US Food and Drug Administration’s (FDA) Center for Veterinary Medicine recently approved Pexion (imepitoin tablets) to treat noise aversion in dogs. It’s a common condition—one study found that 40% of dogs may suffer from some degree of noise aversion—and one with possibly serious health implications, indicates a study that shows that noise aversion in dogs could be a sign of serous pain.